Southeast Minnesota Capital Fund focuses on early-stage investments in innovative, high-growth companies across Minnesota, with a preference for those in Rochester and Southeast Minnesota. The fund primarily targets the healthcare sector, including medical devices, diagnostics, pharmaceuticals, and healthcare IT. Typical investments are made at the seed stage, with occasional participation in later rounds.

The fund's portfolio includes notable companies such as Vyriad (oncology virotherapy), Oculogica (concussion diagnostics), and Sonex Health (carpal tunnel devices). Southeast Minnesota Capital Fund aims to support entrepreneurs building groundbreaking solutions in healthcare and related fields, contributing to the region's growing reputation as a hub for medical innovation.